骨成長刺激装置の市場規模：製品別、用途別、エンドユーザー別、地域別、範囲および予測

骨成長刺激装置の市場規模と予測

骨成長刺激装置の市場規模は、2023年に13億6,000万米ドルと評価され、2024年から2031年にかけてCAGR 5.99%で成長し、2031年には21億7,000万米ドルに達すると予測されています。骨成長刺激装置は、骨の修復と成長を助ける医療機器です。低レベルの電磁場や音響波を発生させて骨細胞を刺激し、骨の成長や修復を促します。この技術は整形外科医療で広く利用されており、骨折の治癒、特に治癒が遅い骨折や、骨がうまく癒合しない非癒合骨折の治癒を助ける。骨成長刺激装置はまた、治癒過程を早める脊椎固定術や、骨を丈夫にして症状を緩和する骨粗鬆症や変形性関節症の治療にも使われています。

さらに、骨成長刺激装置は、骨折や病気に苦しむ患者の治癒を早め、予後を改善する上で重要な役割を果たしています。

骨成長刺激装置の世界市場力学

骨成長刺激装置市場を形成している主な市場力学

主な市場促進要因

骨関連疾患の有病率の増加：

骨粗鬆症、骨折、その他の骨関連疾患の有病率の増加は、骨成長刺激装置産業の主要な促進要因です。世界人口の高齢化に伴い、骨の治癒と再生を改善する効果的な治療に対する需要が高まり、市場成長の原動力になると予想されます。

骨成長刺激装置の技術的進歩：

ポータブルで非侵襲的な選択肢など、骨成長刺激装置の技術的進歩により、治療がより身近で効果的なものになった。このような技術革新は患者の治療成績と利便性を向上させ、より多くのユーザーを惹きつけ、市場の開拓を促進しています。

非外科的治療オプションへの嗜好の高まり：

患者やヘルスケアプロバイダーは、外科的な治療法よりもリスクが低く費用も抑えられる非外科的な治療法を好むようになってきています。骨成長刺激剤は非侵襲的な代替手段を提供するため、人気と市場需要を押し上げています。

政府の支援政策と償還シナリオ：

ヘルスケア・インフラを改善するための政府の努力と、骨成長刺激薬に対する有利な償還規則により、これらの治療法はより安価で利用しやすくなっています。このような規制上の支援により、骨成長刺激薬の使用が促進され、市場の成長を後押ししています。

主な課題

装置と治療の高コスト：

初期購入や継続的な使用を含め、骨成長刺激装置のコストが高いことが市場拡大を制限しています。この高コストが、十分な保険が適用されない患者や低所得地域に住む患者のアクセスを制限し、市場浸透を低下させています。

限られた認識と理解：

潜在的な消費者や特定の医療提供者は、骨成長刺激装置の利点や用途を知らないです。このような情報格差は、人々がこのような治療の選択肢を求めたり薦めたりしないため、採用率を低下させ、市場の拡大を制限します。

代替治療法との競合：

医薬品、外科的技術、その他の非侵襲的治療法は骨成長刺激装置と競合します。これらの代替療法が利用可能であることは、患者や医療提供者の嗜好に影響を与え、骨成長刺激剤の使用を制限します。

主要動向：

スマートテクノロジーの統合：

骨成長刺激装置市場は、IoTやAIのようなスマート技術を使用して、装置の機能性と患者のモニタリングを改善する方向にシフトしています。これらの技術は、個別化された治療レジメンとリアルタイムのデータ追跡を提供し、患者の結果と参加を改善します。

ウェアラブル・デバイスとポータブル・デバイスの拡大：

ウェアラブルで携帯可能な骨成長刺激装置の開発動向が拡大しています。これらのデバイスは、治療効果を維持しながら家庭で快適に使用できるため、非侵襲的で柔軟な治療の選択肢を求める幅広い患者層に魅力的です。

研究開発への注力：

研究開発への投資の増加は、より効率的で効果的な骨成長刺激装置の開発を加速させています。この動向は、併用療法や新しい刺激技術などのブレークスルーにつながっており、業界を発展させ、より良い治療の選択肢を提供することになります。

非侵襲的治療に対する需要の高まり：

患者やヘルスケア専門家がより侵襲的でリスクの低い治療法を求める中、非侵襲的な骨成長刺激装置へのニーズが高まっています。この動向は、ヘルスケアにおける低侵襲治療への幅広い変化を反映しており、骨成長刺激剤は骨の治癒と再生のための最良の選択肢として浮上しています。

目次

第1章 骨成長刺激装置の世界市場イントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 骨成長刺激装置の世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 骨成長刺激装置の世界市場：製品別

• 概要
• 骨成長刺激デバイス
• 骨形態形成タンパク質
• 血小板リッチ血漿

第6章 骨成長刺激装置の世界市場：用途別

• 概要
• 脊椎固定術
• 癒合遅延および非癒合骨折
• 口腔・顎顔面外科手術
• その他

第7章 骨成長刺激装置の世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 骨成長刺激装置の世界市場：競合情勢

• 概要
• 各社の市場ランキング
• 主な発展戦略

第9章 企業プロファイル

• Arthrex, Inc.
• Essex Woodlands Healthcare Partners（Bioventus LLC）
• Colfax Corporation（DJO Global, Inc）
• Isto Biologics
• Johnson & Johnson（Depuy Synthes）
• Medtronic Plc
• Orthofix Medical Inc.
• Stryker Corporation
• Terumo Corporation
• Zimmer Biomet Holdings, Inc.

第10章 付録

• 関連調査

Bone Growth Stimulator Market Size And Forecast

Bone Growth Stimulator Market size was valued at USD 1.36 Billion in 2023 and is projected to reach USD 2.17 Billion by 2031, growing at a CAGR of 5.99% from 2024 to 2031. A bone growth stimulator is a medical device that helps bones mend and grow. It works by generating low-level electromagnetic fields or acoustic waves that stimulate bone cells, causing them to grow and mend. This technology is widely utilized in orthopedic medicine to aid in the healing of fractures, particularly slow-healing or non-union fractures, in which bones fail to mend properly. Bone growth stimulators are also used in spinal fusion procedures to speed up the healing process, as well as in the treatment of osteoporosis and osteoarthritis to strengthen bones and relieve symptoms.

Furthermore, bone growth stimulators serve an important role in expediting healing and improving outcomes for patients suffering from bone fractures or diseases.

Global Bone Growth Stimulator Market Dynamics

The key market dynamics that are shaping the bone growth stimulator market include:

Key Market Drivers

Increasing Prevalence of Bone-Related Disorders:

The increasing prevalence of osteoporosis, fractures, and other bone-related disorders is a major driver of the bone growth stimulator industry. As the world's population ages, the demand for effective treatments to improve bone healing and regeneration rises is expected to drive market growth.

Technological Advancements in Bone Growth Stimulators:

Technological advancements in bone growth stimulators, such as portable and non-invasive choices, have made treatment more accessible and effective. These innovations improve patient outcomes and ease, attracting more users and driving market development.

Growing Preference for Non-Surgical Treatment Options:

Patients and healthcare providers are increasingly preferring non-surgical therapies since they are less risky and less expensive than surgical methods. Bone growth stimulators provide a non-invasive alternative, which boosts their popularity and market demand.

Supportive Government Policies and Reimbursement Scenario:

Government efforts to improve healthcare infrastructure, together with favorable reimbursement rules for bone growth stimulation medicines, have made these therapies more inexpensive and accessible. This regulatory support promotes the use of bone growth stimulators, which drives market growth.

Key Challenges:

High Cost of Devices and Treatment:

The high cost of bone growth stimulators, including initial purchase and continued usage, limits market expansion. This high cost restricts access for patients without adequate insurance coverage or those living in low-income areas, reducing market penetration.

Limited Awareness and Understanding:

Potential consumers and certain healthcare providers are unaware of the benefits and applications of bone growth stimulators. This information gap reduces the adoption rate since people may not seek out or recommend these treatment choices, limiting market expansion.

Competition from Alternative Treatment Options:

Pharmaceuticals, surgical techniques, and other non-invasive therapies compete with bone growth stimulators. The availability of these alternatives influences patient and provider preferences, which limits the use of bone growth stimulators.

Key Trends:

Integration of Smart Technologies:

The bone growth stimulator market is experiencing a shift towards the use of smart technologies like IoT and AI to improve device functionality and patient monitoring. These technologies offer personalized treatment regimens and real-time data tracking, which improves patient results and participation.

Expansion of Wearable and Portable Devices:

There is a growing trend in developing wearable and portable bone growth stimulators. These devices provide the comfort of home use while maintaining treatment efficacy, making them appealing to a broader patient demography looking for non-invasive and flexible treatment choices.

Focus on Research and Development:

Increased investment in R&D is accelerating the development of more efficient and effective bone growth stimulators. This trend is leading to breakthroughs such as combining therapies and novel stimulation techniques, which will advance the industry and provide better healing options.

Rising Demand for Non-Invasive Treatments:

As patients and healthcare professionals seek less intrusive and lower-risk treatment choices, the need for non-invasive bone growth stimulators is increasing. This trend reflects a broader change in healthcare towards minimally invasive therapies, with bone growth stimulators emerging as a top choice for bone healing and regeneration.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Bone Growth Stimulator Market Regional Analysis

Here is a more detailed regional analysis of the bone growth stimulator market:

North America:

According to Verified Market Research, North America is estimated to dominate the bone growth stimulator market during the forecast period. North America, particularly the United States, has a sophisticated healthcare system that places a significant focus on innovation and technological uptake. This environment promotes the development and early use of innovative medical devices, such as bone growth stimulators, which drives market expansion in the region.

The region has a high incidence of bone-related disorders such as osteoporosis and fractures, particularly among the elderly. This demographic trend raises the demand for effective bone healing therapies, making bone growth stimulators more popular.

Many top medical device companies and research institutions focused on the development of bone growth stimulators are based in North America. The region's market dominance is maintained by a strong concentration on R&D, backed up by large investment.

Furthermore, the United States, in particular, has advantageous healthcare payment rules that cover a wide range of treatments, including the usage of bone growth stimulators. These regulations make therapies more accessible to patients and stimulate the use of innovative medical equipment, which helps the industry grow in North America.

Asia Pacific:

Asia Pacific is experiencing a significant rise in the ageing population, particularly in Japan and China. This demographic transition increases the frequency of bone-related disorders such as osteoporosis and fractures, driving up demand for bone growth stimulators in the region

Many Asia Pacific countries are quickly expanding their healthcare infrastructure and boosting healthcare spending. This advancement increases access to innovative medical treatments and technology, such as bone growth stimulators, driving market growth.

Furthermore, economic expansion in the Asia Pacific region is resulting in greater healthcare investments from both governments and private enterprises. This financial assistance promotes the use of innovative medical equipment, such as bone growth stimulators, as part of larger initiatives to enhance healthcare results.

Europe:

Europe has a high rate of sports-related injuries and orthopedic surgeries due to active participation in sports and an ageing population. This increases the demand for effective rehabilitation and bone healing solutions, such as bone growth stimulators, to assure a speedy and complete recovery.

European countries have well-developed healthcare systems that provide complete coverage, including innovative medical devices. This makes bone growth stimulators more accessible to a wider spectrum of patients, boosting regional market growth.

Furthermore, in Europe, there is a rising preference for non-invasive treatment options over traditional surgical treatments due to their shorter recovery times and decreased risk of problems. This tendency encourages the use and market expansion of bone growth stimulators as a noninvasive therapeutic option.

Global Bone Growth Stimulator Market: Segmentation Analysis

The Bone Growth Stimulator Market is segmented based on Product, Application, End User and Geography.

Bone Growth Stimulator Market, By Product

• Bone Growth Stimulation Devices
• Bone Morphogenetic Proteins
• Platelet-rich Plasma

Based on Product, the market is segmented into Bone Growth Stimulation Devices, Bone Morphogenetic Proteins and Platelet-rich Plasma. The bone growth stimulation devices segment is estimated to dominate the bone growth stimulator market due to a variety of causes, including the devices' wide range of applications in expediting fracture healing and promoting bone formation after surgery. Bone growth stimulation devices, which include both invasive and non-invasive technologies, are a diverse and effective alternative for patients looking to improve their bone health without undergoing additional procedures. Their ease of use, combined with the flexibility to be used in outpatient settings, contributes greatly to their appeal.

Bone Growth Stimulator Market, By Application

• Spinal Fusion Surgeries
• Delayed Union & Nonunion Bone Fractures
• Oral & Maxillofacial Surgeries
• Other Applications

Based on Application, the market is segmented into Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries and Others. The spinal fusion surgeries segment is estimated to dominate the bone growth stimulator market during the forecast period due to the rising incidence of spinal illnesses, such as degenerative disc degeneration and spinal stenosis, particularly among the elderly. Spinal fusion surgery is a typical treatment for these problems, which aims to relieve pain and restore spinal stability. Bone growth stimulators are essential for accelerating bone healing after surgery, ensuring successful fusion and recovery. Their efficiency in improving surgical outcomes, combined with the increasing number of spinal fusion procedures conducted worldwide, boosts demand and market share for this application segment.

Bone Growth Stimulator Market, By End User

• Hospitals and Ambulatory Surgical Centers
• Home Care Settings
• Academic and Research Institutes

Based on the End User, the bone growth stimulator market is divided into Hospitals & Ambulatory Surgical Centers, Home Care Settings, and Academic & Research Institutes. The hospitals and ambulatory surgical centers segment is estimated to dominate the market over the forecast period. The complex nature and severity of cases treated in these settings often require the use of modern medical equipment, such as bone growth stimulators, to ensure the best patient results. Hospitals and ambulatory surgical centres have the required infrastructure and qualified experts to deliver such treatments efficiently. Furthermore, these settings are more likely to be the first line of treatment for injuries and diseases that require bone development stimulation, such as fractures or operations.

Bone Growth Stimulator Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Geography, the bone growth stimulator market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is expected to dominate during the forecasted period owing to the region's advanced healthcare infrastructure, a high frequency of bone-related disorders, significant R&D investments, and favourable healthcare legislation, such as extensive reimbursement schemes. The United States, in particular, plays an important role in driving the market due to its high healthcare spending, emphasis on breakthrough medical technology, and big ageing population that demands bone-related treatments.

Key Players

• The "Bone Growth Stimulator Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Zimmer Biomet, Stryker Corporation, Johnson & Johnson, Ossur hf., B. Braun Melsungen AG, DJO Global, Arthrogenix, IEX Medical, EMS Physiotherapy Equipment Ltd., SONOSTAT, Alvar, SPIRE Corp., Stimulation Technologies, DJO Surgical, Donjoy and EBI Medical Products.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In February 2024, Mainstay Medical announced a US$125 million equity financing transaction. This announcement shows a large investment in the bone growth stimulator field, which could indicate further market expansion and development.
• In February 2024, Orthofix received FDA and CE Mark Approval for New Bone Growth Stimulants. This highlights regulatory approvals for new bone growth stimulators, highlighting prospective advances in technology and therapy choices.
• In February 2024, SI-BONE, Inc., a corporation specializing in sacroiliac joint fusion with minimally invasive procedures, published financial results and guided 2024.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL BONE GROWTH STIMULATOR MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL BONE GROWTH STIMULATOR MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL BONE GROWTH STIMULATOR MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Bone Growth Stimulation Devices
• 5.3 Bone Morphogenetic Proteins
• 5.4 Platelet-Rich Plasma

6 GLOBAL BONE GROWTH STIMULATOR MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Spinal Fusion Surgeries
• 6.3 Delayed Union & Nonunion Bone Fractures
• 6.4 Oral & Maxillofacial Surgeries
• 6.5 Others

7 GLOBAL BONE GROWTH STIMULATOR MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East and Africa

8 GLOBAL BONE GROWTH STIMULATOR MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Arthrex, Inc.
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Essex Woodlands Healthcare Partners (Bioventus LLC)
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Colfax Corporation (DJO Global, Inc)
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Isto Biologics
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Johnson & Johnson (Depuy Synthes)
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Medtronic Plc
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Orthofix Medical Inc.
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Stryker Corporation
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Terumo Corporation
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Zimmer Biomet Holdings, Inc.
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments

10 Appendix

• 10.1 Related Research